Merck drug extends survival in endometrial cancer trial, wins U.S. priority review
The drug delivers a cancer-killing payload to cells that carry a protein common in endometrial tumours
· 10/27/2026, 12:33:29 PM· 2 min read
The drug delivers a cancer-killing payload to cells that carry a protein common in endometrial tumours
Read original story →Related stories
health
Ebola scientists to probe Nigeria case origin, Africa CDC says
health
Tobacco use disparities persist despite declining consumption in India, US: Study
health
India’s anaemia problem: an ambitious programme to combat it, but no data to measure it
health